Please assess the completion status of the following clinical trial:

Trial Title: Vitamine D Treatment in Chronic Heart Failure

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: DOUBLE
- Phase: PHASE3
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~* NYHA II-IV~* vitamin D level between 10-30 ng/ml~* ejection fraction by ultrasound \< 40 %~Exclusion Criteria:~* blood calcium \> 2,6 mmol/l~* urinary calcium \> 0,1 mmol/body weight kg/die~* blood phosphorus \> 1,45 mmol/l~* nephrolithiasis in the history~* GFR \< 30 ml/min~* vitamin D injection in the last 6 month~* actual 1,25-OH2-D3 vitamin treatment~* Myocardial infarction or serious coronaria stenosis in the anamnesis uncontrolled atrial fibrillation~* serious valve disease

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: 99 Years
- Healthy Volunteers: f

Study Arms:
- 25-OH-D3 vitamin (Type: EXPERIMENTAL): 180 000 IU 25-OH-D3 vitamin oil per os, per month in the 0, 1, 2, 3, and 6 month at the visit. The patient take the drug under medical control
- MCT oil (Type: PLACEBO_COMPARATOR): 9 ml MCT oil as placebo in the 0,1,2,3,6 month at the visit, under medical contol

Based on this trial design, predict the completion outcome and termination type (if applicable).